129 related articles for article (PubMed ID: 10431763)
1. Involvement of platelet-activating factor in the modulation of vascular tone in the isolated perfused rabbit kidney.
Cailleaux S; Lopes-Martins RA; Aimbire F; Cordeiro RS; Tibiriçá E
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):505-11. PubMed ID: 10431763
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidence of a role for platelet activating factor as a modulator of vasomotor tone and blood pressure.
Lopes-Martins R; Catelli M; Araújo C; Estato V; Cordeiro R; Tibiriçá E
Eur J Pharmacol; 1996 Jul; 308(3):287-94. PubMed ID: 8858301
[TBL] [Abstract][Full Text] [Related]
3. Platelet-activating factor. A possible role in the modulation of the vasomotor tone and blood pressure.
Lopes-Martins RA; Araújo CV; Estato V; Moreira S; Cordeiro RS; Tibiriçá EV
Adv Exp Med Biol; 1996; 416():223-30. PubMed ID: 9131152
[No Abstract] [Full Text] [Related]
4. The acute increases in vasomotor tone and blood pressure induced by carotid artery occlusion are modulated by platelet-activating factor (PAF) independently of nitric oxide release.
Lopes-Martins RA; Estato V; Araújo CV; Catelli M; Cordeiro RS; Tibiriçá E
J Lipid Mediat Cell Signal; 1997 Dec; 17(3):151-65. PubMed ID: 9524924
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of yangambin on cardiovascular hyporeactivity to catecholamines in rats with endotoxin-induced shock.
Araújo CV; Barbosa-Filho JM; Cordeiro RS; Tibiriçá E
Naunyn Schmiedebergs Arch Pharmacol; 2001 Mar; 363(3):267-75. PubMed ID: 11284440
[TBL] [Abstract][Full Text] [Related]
6. Antagonism of vasoconstriction induced by platelet-activating factor in guinea-pig perfused hearts by selective platelet-activating factor receptor antagonists.
Piper PJ; Stewart AG
Br J Pharmacol; 1987 Apr; 90(4):771-83. PubMed ID: 3034369
[TBL] [Abstract][Full Text] [Related]
7. Effects of PAF antagonists on renal vascular escape and tachyphylaxis in perfused rabbit kidney.
Ferreira MG; Braquet P; Fonteles MC
Lipids; 1991 Dec; 26(12):1329-32. PubMed ID: 1819726
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the vasodilatory effects of bradykinin in isolated dog renal arteries and in buffer-perfused dog kidneys.
Malomvölgyi B; Hadházy P; Tekes K; Koltai MZ; Pogátsa G
Acta Physiol Hung; 1996; 84(1):9-18. PubMed ID: 8993670
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor modulates pulmonary vasomotor tone in the perinatal lamb.
Ibe BO; Hibler S; Raj JU
J Appl Physiol (1985); 1998 Sep; 85(3):1079-85. PubMed ID: 9729586
[TBL] [Abstract][Full Text] [Related]
10. Interaction of vasoactive substances released by platelet-activating factor in the rat perfused heart.
Hu WM; Man RY
Br J Pharmacol; 1991 Dec; 104(4):933-7. PubMed ID: 1810604
[TBL] [Abstract][Full Text] [Related]
11. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: in vivo pharmacological studies.
Castro-Faria-Neto HC; Araújo CV; Moreira S; Bozza PT; Thomas G; Barbosa-Filho JM; Cordeiro RS; Tibiriçá EV
Planta Med; 1995 Apr; 61(2):106-12. PubMed ID: 7753914
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.
Seale JP; Nourshargh S; Hellewell PG; Williams TJ
Br J Pharmacol; 1991 Sep; 104(1):251-7. PubMed ID: 1786514
[TBL] [Abstract][Full Text] [Related]
13. Partial agonist effect of the platelet-activating factor receptor antagonists, WEB 2086 and WEB 2170, in the rat perfused heart.
Hu W; McNicholl IK; Choy PC; Man RY
Br J Pharmacol; 1993 Oct; 110(2):645-50. PubMed ID: 8242237
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide inhibition does not prevent the hypotensive response to increased renal perfusion in rabbits.
Thomas CJ; Anderson WP; Woods RL
Clin Exp Pharmacol Physiol; 1995 May; 22(5):345-51. PubMed ID: 7554426
[TBL] [Abstract][Full Text] [Related]
15. Role of nitric oxide and platelet-activating factor in cardiac alterations induced by tumor necrosis factor-alpha in the guinea-pig papillary muscle.
Alloatti G; Penna C; De Martino A; Montrucchio G; Camussi G
Cardiovasc Res; 1999 Mar; 41(3):611-9. PubMed ID: 10435033
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor-induced coronary constriction in the isolated perfused guinea pig heart and antagonistic effects of the PAF antagonist WEB 2086.
Felix SB; Steger A; Baumann G; Busch R; Ochsenfeld G; Berdel WE
J Lipid Mediat; 1990; 2(1):9-20. PubMed ID: 2133268
[TBL] [Abstract][Full Text] [Related]
17. Yangambin: a new naturally-occurring platelet-activating factor receptor antagonist: binding and in vitro functional studies.
Castro-Faria-Neto HC; Bozza PT; Cruz HN; Silva CL; Violante FA; Barbosa-Filho JM; Thomas G; Martins MA; Tibiriçá EV; Noel F
Planta Med; 1995 Apr; 61(2):101-5. PubMed ID: 7753913
[TBL] [Abstract][Full Text] [Related]
18. Interaction between platelet-aggregating response and vasoconstrictive response to platelet activating factor.
Michibayashi T
J Smooth Muscle Res; 1999 Aug; 35(4):111-24. PubMed ID: 10647808
[TBL] [Abstract][Full Text] [Related]
19. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs.
Noguchi K; Matsuzaki T; Shiroma N; Ojiri Y; Sakanashi M
Br J Pharmacol; 1996 Jun; 118(4):941-50. PubMed ID: 8799566
[TBL] [Abstract][Full Text] [Related]
20. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo.
Handa RK; Strandhoy JW; Handa SE
Kidney Blood Press Res; 2003; 26(3):165-75. PubMed ID: 12886044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
